Parkinsonism-Hyperpyrexia Syndrome — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Parkinsonism-hyperpyrexia syndrome (neuroleptic malignant-like syndrome)
Parkinsonism-hyperpyrexia syndrome (also called neuroleptic malignant-like syndrome or dopaminergic withdrawal syndrome) occurs when dopaminergic medication is abruptly withdrawn in Parkinson's disease. It presents identically to NMS (rigidity, hyperthermia, autonomic instability, raised CK, altered consciousness) and is a medical emergency. Treatment is immediate reinstatement of dopaminergic therapy, IV fluids, dantrolene, and cooling. A: Serotonin syndrome has clonus and hyperreflexia as distinguishing features. B: NMS is caused by dopamine antagonists, not dopaminergic withdrawal, though the pathophysiology overlaps. D: Malignant hyperthermia is anaesthesia-related. E: Sepsis is possible but the temporal relationship to medication withdrawal is diagnostic.
Reference: NICE NG71 Parkinson's Disease (2017); Newman et al. Movement Disorders (2009)